These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 274738)

  • 1. Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.
    Boon T; Van Pel A
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1519-23. PubMed ID: 274738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.
    Boon T; Kellermann O
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):272-5. PubMed ID: 264681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.
    Van Pel A; Georlette M; Boon T
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5282-5. PubMed ID: 291945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
    Uyttenhove C; Van Snick J; Boon T
    J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
    Boon T; Maryanski J
    Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.
    Van Pel A; Boon T
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4718-22. PubMed ID: 6981814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
    Maryanski JL; Marchand M; Uyttenhove C; Boon T
    Int J Cancer; 1983 Jan; 31(1):119-23. PubMed ID: 6187698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumor.
    Georlette M; Boon T
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1083-7. PubMed ID: 7200017
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
    Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
    J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.
    Van Pel A; Vessière F; Boon T
    J Exp Med; 1983 Jun; 157(6):1992-2001. PubMed ID: 6602203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts.
    Siesjö P; Visse E; Lindvall M; Salford L; Sjögren HO
    Cancer Immunol Immunother; 1993 Jul; 37(1):67-74. PubMed ID: 8513454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes.
    Vessière F; Georlette M; Warnier G; Leclerc JC; Van Pel A; Boon T
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):867-74. PubMed ID: 6185345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
    Maryanski JL; Szpirer J; Szpirer C; Boon T
    Somatic Cell Genet; 1983 May; 9(3):345-57. PubMed ID: 6407125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic capacity of tum--variants isolated from a rat rhabdomyosarcoma.
    Pauwels-Vergely C; Poupon MF
    Br J Cancer; 1987 Jul; 56(1):7-13. PubMed ID: 2956985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW; Romerdahl CA; Kripke ML
    Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
    Peppoloni S; Herberman RB; Gorelik E
    Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratocarcinoma transplantation antigens are encoded in the H-2 region.
    Johnson LL; Clipson LJ; Dove WF; Feilbach J; Maher LJ; Shedlovsky A
    Immunogenetics; 1983; 18(2):137-45. PubMed ID: 6350173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
    Van Snick J; Maryanski J; Van Pel A; Parmiani G; Boon T
    Eur J Immunol; 1982 Nov; 12(11):905-8. PubMed ID: 6818041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma.
    Zbar B; Sukumar S; Tanio Y; Terata N; Hovis J
    Cancer Res; 1984 Nov; 44(11):5079-85. PubMed ID: 6488168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.